FAB-144 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB<sub>1</sub> receptor and has been sold online as a designer drug. It is the indazole analogue of XLR-11.
Sweden's public health agency suggested classifying FAB-144 as a hazardous substance on November 10, 2014.